Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
383
datasets available to search
ShareScore release 0.9.0
Dataset results
383 results for “gvhd”
Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention
ClinicalTrials.gov study NCT04503616. IPD Sharing: YES. Countries: 1. Publications: 1.
Study of orBec® With Prednisone Therapy in the Treatment of Patients With Graft Versus Host Disease (GVHD)
ClinicalTrials.gov study NCT00926575. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors
ClinicalTrials.gov study NCT01323920. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT
ClinicalTrials.gov study NCT01012492. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7
ClinicalTrials.gov study NCT02663622. IPD Sharing: YES. Countries: 1. Publications: 4.
Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)
ClinicalTrials.gov study NCT00406393. IPD Sharing: YES. Countries: 2. Publications: 1.
Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation
ClinicalTrials.gov study NCT00803010. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of Ruxolitinib vs Best Available Therapy (BAT) in Patients With Steroid-refractory Chronic Graft vs. Host Disease (GvHD) After Bone Marrow Transplantation (REACH3)
ClinicalTrials.gov study NCT03112603. IPD Sharing: NO. Countries: 31. Publications: 5.
Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS
ClinicalTrials.gov study NCT00025662. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Atorvastatin for the Prophylaxis of Acute GVHD in Patients Undergoing Matched Sibling Allogeneic Transplantation
ClinicalTrials.gov study NCT01175148. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation
ClinicalTrials.gov study NCT00369226. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Study of TelmisartanFor the Prevention of Acute GVHD Post Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT02338232. IPD Sharing: Not stated. Countries: 1. Publications: 108.
Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT
ClinicalTrials.gov study NCT03018223. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With L
ClinicalTrials.gov study NCT00928018. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Novel BET Inhibitor PLX51107 for Steroid-Refractory Acute GVHD
ClinicalTrials.gov study NCT04910152. IPD Sharing: NO. Countries: 1. Publications: 0.
FMT In High-Risk Acute GVHD After ALLO HCT
ClinicalTrials.gov study NCT04139577. IPD Sharing: YES. Countries: 1. Publications: 1.
A Dose-Finding Study of Vedolizumab for Treatment of Steroid-Refractory Acute Intestinal Graft-Versus-Host Disease (GvHD) in Participants Who Have Undergone Allogeneic Hematopoietic Stem Cell Transpla
ClinicalTrials.gov study NCT02993783. IPD Sharing: YES. Countries: 5. Publications: 1.
PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation
ClinicalTrials.gov study NCT05120570. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation
ClinicalTrials.gov study NCT01665677. IPD Sharing: NO. Countries: 1. Publications: 7.
Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation
ClinicalTrials.gov study NCT03246906. IPD Sharing: NO. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.